Skip to main content
logo
Sinew Pharma Inc. (TPEX:6634)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
53.50
+1.80 (3.48%)
Sep 8, 2026, 12:18 PM CST

Sinew Pharma Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.050.05--0.336.23
Revenue Growth
0%----94.73%1248.27%
Gross Profit
0.040.04--0.295.09
Operating Income
-133.08-140.13-168.86-186.25-148.43-94.42
Net Income
-118.43-123.75-150.37-170.92-140.18-91.58
Earnings Per Share
-1.66-1.74-2.11-2.43-2.02-1.54
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
995.271,0521,1591,2751,3911,483
Total Debt
12.2715.212.829.287.551.05
Net Cash (Debt)
9831,0371,1561,2661,3841,482
Net Cash Growth
-5.20%-10.32%-8.68%-8.48%-6.61%342.31%
Net Cash Per Share
13.7914.5916.2117.9719.9724.90

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-97.67-95.3-106.08-118.05-93.76-57.32
Capital Expenditures
-0.66-0.63-0.18-7.21-5.23-2.18
Free Cash Flow
-98.33-95.93-106.26-125.26-98.99-59.5
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
78.72%78.72%--88.41%81.75%
Operating Margin
-283142.55%-298140.43%---45252.44%-1515.81%
Pretax Margin
-251980.85%-263287.23%---42737.80%-1470.14%
Profit Margin
-251980.85%-263287.23%---42737.81%-1470.14%
FCF Margin
-209212.77%-204112.77%---30178.66%-955.19%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
78446.3859405.82--22335.55908.45